What's in RHEACELL GmbH & Co. KG's pipeline?

RHEACELL GmbH & Co. KG has 5 drugs in our index: 0 marketed, 0 filed, 2 in Phase 3, 0 in Phase 2, 3 in Phase 1.

Which companies overlap with RHEACELL GmbH & Co. KG's portfolio?

Top competitors by shared drug class: AbbVie (prior sponsor, Abbott), Bausch & Lomb Incorporated, Biogen, Celgene, Geropharm.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/rheacell-gmbh-co-kg.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

RHEACELL GmbH & Co. KG — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

RHEACELL GmbH & Co. KG pipeline: 0 marketed, 0 filed, 2 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 2 Phase 3 0 Phase 2 3 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
allo-APZ2-OTS	allo-APZ2-OTS	phase 3	S1P receptor modulator	S1PR1	Autoimmune diseases
allo-APZ2-CVU	allo-APZ2-CVU	phase 3		CVU receptor

Therapeutic area mix

Autoimmune diseases · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

AbbVie (prior sponsor, Abbott) · 1 shared drug class
Bausch & Lomb Incorporated · 1 shared drug class
Biogen · 1 shared drug class
Celgene · 1 shared drug class
Geropharm · 1 shared drug class
GlaxoSmithKline · 1 shared drug class
Hoffmann-La Roche · 1 shared drug class
AO GENERIUM · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for RHEACELL GmbH & Co. KG:

Cite this brief

Drug Landscape (2026). RHEACELL GmbH & Co. KG — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/rheacell-gmbh-co-kg. Accessed 2026-05-17.